Australian biotech giant CSL is primed to make its first acquisition since announcing a devastating round of lay-offs, considering a takeover of its partner in a new surgical aid venture.

Shareholders continued to sell down CSL despite its investment in a blood disorder biotech, saying they want more signs of ...

Druid AI today announced it has secured USD 31 million in Series C financing to advance the global expansion of its ...

Aguia Resources has delivered a powerful update for its Brazilian Tres Estrades project, with its pre-tax free cash flow ...